ARTICLE | Company News
Caris Life Sciences, Miraca deal
October 17, 2011 7:00 AM UTC
Holding company Miraca will acquire the anatomic pathology business operated by Caris' Caris Diagnostics Inc. subsidiary for $725 million in cash. The deal does not include Caris' Target Now molecula...